Yong Rong (Hk) Asset Management LTD Legend Biotech Corp Transaction History

Yong Rong (Hk) Asset Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$31.02 - $48.18 $4.03 Million - $6.26 Million	-130,000 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$41.14 - $56.98 $4.12 Million - $5.71 Million	100,249 Added 336.96%	130,000 $6.06 Million
Q3 2021 Oct 28, 2021	BUY	$35.31 - $50.56 $1.05 Million - $1.5 Million	29,751 New	29,751 $1.51 Million
Q2 2021 Aug 03, 2021	SELL	$25.8 - $41.09 $5.12 Million - $8.15 Million	-198,312 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$25.8 - $32.39 $3.96 Million - $4.97 Million	153,312 Added 340.69%	198,312 $5.59 Million
Q3 2020 Nov 03, 2020	BUY	$27.5 - $39.61 $1.24 Million - $1.78 Million	45,000 New	45,000 $1.39 Million

233

86.1M

260K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.37B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Yong Rong (Hk) Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Yong Rong (Hk) Asset Management LTD with notifications on news.